MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

A

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

Search

STAAR Surgical Co

Затворен

СекторЗдравеопазване

20.96 -0.1

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

20.58

Максимум

21.02

Ключови измерители

By Trading Economics

Приходи

-62M

8.9M

Продажби

-44B

95M

Марж на печалбата

9.378

Служители

1,157

EBITDA

26M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+4.53% upside

Дивиденти

By Dow Jones

Следващи печалби

18.02.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-160M

1.1B

Предишно отваряне

21.06

Предишно затваряне

20.96

Настроения в новините

By Acuity

46%

54%

126 / 361 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

STAAR Surgical Co Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

6.01.2026 г., 15:11 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9.12.2025 г., 18:51 ч. UTC

Придобивния, сливания и поглъщания

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9.12.2025 г., 15:54 ч. UTC

Значими двигатели на пазара
Придобивния, сливания и поглъщания

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9.12.2025 г., 14:32 ч. UTC

Придобивния, сливания и поглъщания

Alcon Upgrades Offer Price for Staar Surgical

7.11.2025 г., 15:42 ч. UTC

Придобивния, сливания и поглъщания

Alcon, Staar Surgical Amend Merger Agreement to Allow Other Bids

7.01.2026 г., 01:00 ч. UTC

Придобивния, сливания и поглъщания

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6.01.2026 г., 22:03 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6.01.2026 г., 22:03 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6.01.2026 г., 15:21 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6.01.2026 г., 14:56 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6.01.2026 г., 14:14 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6.01.2026 г., 14:14 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6.01.2026 г., 14:14 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6.01.2026 г., 14:13 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9.12.2025 г., 14:17 ч. UTC

Придобивния, сливания и поглъщания

Alcon Ups Offer Price for Staar Surgical

9.12.2025 г., 13:34 ч. UTC

Придобивния, сливания и поглъщания

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9.12.2025 г., 13:33 ч. UTC

Придобивния, сливания и поглъщания

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9.12.2025 г., 13:33 ч. UTC

Придобивния, сливания и поглъщания

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9.12.2025 г., 13:33 ч. UTC

Придобивния, сливания и поглъщания

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

9.12.2025 г., 13:32 ч. UTC

Придобивния, сливания и поглъщания

Alcon: "Go-shop" Window Expired on Dec 6 >ALC.EB

9.12.2025 г., 13:32 ч. UTC

Придобивния, сливания и поглъщания

Alcon: Transaction Now Represents Total Equity Value of About $1.6B >ALC

9.12.2025 г., 13:31 ч. UTC

Придобивния, сливания и поглъщания

Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC

9.12.2025 г., 13:31 ч. UTC

Придобивния, сливания и поглъщания

Alcon Announces Amended Merger Agreement With STAAR Surgical

9.12.2025 г., 13:31 ч. UTC

Придобивния, сливания и поглъщания

Alcon Enters Amended Merger Agreement for Acquisition of STAAR Surgical >ALC

7.11.2025 г., 15:11 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: Alcon Waives All Matching Rights for Third-Party Proposals, Info Rights During Go Shop Period >STAA

7.11.2025 г., 15:10 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: No Termination Fee Payable to Alcon if STAAR Terminates Merger Agreement to Accept a Superior Proposal From a Qualified Bidder >STAA

7.11.2025 г., 15:10 ч. UTC

Придобивния, сливания и поглъщания

STAAR Surgical Announces Amendments to Alcon Merger Agreement

27.10.2025 г., 12:02 ч. UTC

Придобивния, сливания и поглъщания

STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions With Alcon

8.10.2025 г., 15:44 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8.10.2025 г., 15:44 ч. UTC

Придобивния, сливания и поглъщания

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

Сравнение с други в отрасъла

Ценова промяна

STAAR Surgical Co Прогноза

Ценова цел

By TipRanks

4.53% нагоре

12-месечна прогноза

Среден 21.92 USD  4.53%

Висок 30.75 USD

Нисък 13 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за STAAR Surgical Co през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

5 ratings

0

Купи

4

Задържане

1

Продай

Техническа оценка

By Trading Central

18.604 / 20.07Подкрепа & съпротива

Краткосрочен план

Strong Bullish Evidence

Средносрочен план

Very Strong Bullish Evidence

Дългосрочен план

No Evidence

Настроение

By Acuity

126 / 361 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat